Latest News from: University of Miami Health System, Miller School of Medicine

Filters close
Newswise: Sylvester Study: MRI Provides Early Warning System for Glioblastoma Growth
26-Sep-2024 4:05 PM EDT
Sylvester Study: MRI Provides Early Warning System for Glioblastoma Growth
Sylvester Comprehensive Cancer Center

A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time. It is the first to quantify tumor changes in glioblastoma patients receiving MRI-guided radiation therapy.

Released: 30-Sep-2024 2:05 PM EDT
Breast Cancer Experts & Story Ideas
University of Miami Health System, Miller School of Medicine

Sylvester Comprehensive Cancer Center experts attack breast cancer on multiple fronts to advance cures, reduce racial disparities and save lives. New imaging and surgical techniques help.

Not for public release

This news release is embargoed until 27-Sep-2024 5:00 PM EDT Released to reporters: 25-Sep-2024 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: ASTRO Presidential Symposium Presentation Will Focus on Leading-Edge Microboost Technology for Prostate Cancer
Released: 26-Sep-2024 12:05 PM EDT
ASTRO Presidential Symposium Presentation Will Focus on Leading-Edge Microboost Technology for Prostate Cancer
Sylvester Comprehensive Cancer Center

Microboost technology -- a leading-edge approach to targeted radiation treatment for prostate cancer -- will be the topic of Dr. Brandon Mahal's Presidential Symposium presentation next week at the American Society for Radiation Oncology (ASTRO) meeting.

Newswise: 26-Year-Old Ph.D. Candidate Diagnosed With Rare Form of Breast Cancer - Two Separate Tumors in Different Breast Quadrants
Released: 25-Sep-2024 2:05 PM EDT
26-Year-Old Ph.D. Candidate Diagnosed With Rare Form of Breast Cancer - Two Separate Tumors in Different Breast Quadrants
Sylvester Comprehensive Cancer Center

LaShae Rolle, a Ph.D. candidate was just 26 when she was diagnosed with a rare type of breast cancer. She is now designing clinical trials and studies focused on underserved and marginalized minority communities – especially adolescents and young adults.

Released: 3-Sep-2024 7:05 PM EDT
ASTRO 2024 Tip Sheet From Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center

Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami will be presented at ASTRO 2024 – the American Society for Radiation Oncology’s annual meeting Sept. 29 – Oct. 2 in Washington D.C. Below are titles for oral presentations, posters and special sessions in which our researchers will be involved.

Released: 3-Sep-2024 1:05 PM EDT
Experts on the front lines of blood cancer see hope for cures
Sylvester Comprehensive Cancer Center

Expert sources and news tips from Sylvester Comprehensive Cancer Center for Blood Cancer Awareness Month in September.

Newswise: Study: Some Lung Cancer Disparities Lessen in South Florida
Released: 25-Aug-2024 11:05 PM EDT
Study: Some Lung Cancer Disparities Lessen in South Florida
Sylvester Comprehensive Cancer Center

When it comes to cancer disparities, community may count. A new study in the Journal of the National Cancer Institute showed that although Hispanic non-small cell lung cancer patients tend to be diagnosed at later stages than White patients, that disadvantage disappears in South Florida.

Released: 22-Aug-2024 5:05 PM EDT
Sylvester Cancer Tip Sheet - August 2024
Sylvester Comprehensive Cancer Center

A mouthwash-like rinse to predict head and neck cancer recurrence, new research identifies biomarkers to predict which colon cancer patients benefit from adjuvant chemotherapy, the Dolphins Cancer Challenge and more are included in this month's tip sheet.

Newswise: Can a Mouthwash-based Test Help Predict Head and Neck Cancer Recurrence?
14-Aug-2024 6:05 PM EDT
Can a Mouthwash-based Test Help Predict Head and Neck Cancer Recurrence?
Sylvester Comprehensive Cancer Center

Mouthwash has long been marketed as an essential hygiene item to prevent bad breath. But what if a mouthwash-based test to detect biomarkers can help predict recurrence of head and neck cancer?

Newswise: JAMA Oncology Review: The Latest Treatment Options for Acute Myeloid Leukemia
Released: 9-Aug-2024 1:05 AM EDT
JAMA Oncology Review: The Latest Treatment Options for Acute Myeloid Leukemia
Sylvester Comprehensive Cancer Center

New drug combinations and targeted therapies may offer a brighter future for patients with acute myeloid leukemia – especially among older adults and others who may be more frail. A review in JAMA Oncology.

Newswise: UHealth Surgery Team Saves Young Man’s Eye
Released: 5-Aug-2024 3:05 PM EDT
UHealth Surgery Team Saves Young Man’s Eye
University of Miami Health System, Miller School of Medicine

A multidisciplinary surgery team removed a bony tumor to help Joshua Harrison regain his vision without visible scarring.

Released: 30-Jul-2024 10:30 AM EDT
Expert on Alzheimer’s Therapeutic Development AAIC 2024
University of Miami Health System, Miller School of Medicine

Our grant proprosal is to identify how two protective mechanisms work and then test them in both European and Amerindian APOE4 genes to see if they work in those genetic backgrounds as well as African.

Newswise: Study Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy
Released: 26-Jul-2024 4:05 PM EDT
Study Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy
Sylvester Comprehensive Cancer Center

A new study identifies and validates a 10-gene biomarker that potentially predicts whether a stage II or III colon cancer patient will benefit from adjuvant chemotherapy. A secondary finding from the study suggests that the gene signature could potentially also predict whether immunotherapy would help some patients.

Newswise: Three Junior Faculty Members Join Sylvester Comprehensive Cancer Center’s K12 Faculty Scholars at Annual Symposium
Released: 25-Jul-2024 2:05 PM EDT
Three Junior Faculty Members Join Sylvester Comprehensive Cancer Center’s K12 Faculty Scholars at Annual Symposium
Sylvester Comprehensive Cancer Center

Three junior faculty members at Sylvester Comprehensive Cancer Center have been named K12 2024 Faculty Scholars. The program awards recipients with resources to pursue independent research careers in clinical and translational cancer research.

Not for public release

This news release is embargoed until 25-Jul-2024 9:05 AM EDT Released to reporters: 24-Jul-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2024 9:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Jul-2024 5:05 PM EDT
Sylvester Science Contributes to Guidelines for Anal Cancer
Sylvester Comprehensive Cancer Center

Federal health officials recently released new guidelines for anal cancer screening to protect people with HIV, an achievement made possible by a landmark study conducted at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and Jackson Memorial Hospital, and other research institutions.

Newswise: Physician First in U.S. to Use Blue Laser for Early Vocal Fold Cancer
Released: 9-Jul-2024 12:05 PM EDT
Physician First in U.S. to Use Blue Laser for Early Vocal Fold Cancer
University of Miami Health System, Miller School of Medicine

A Sylvester Comprehensive Cancer Center surgeon was the first in the U.S. to use the 445-nm blue laser for early glottic cancer, the most common type of laryngeal cancer.

Newswise: Sunscreen Is Your Best Friend This Summer
Released: 28-Jun-2024 4:05 PM EDT
Sunscreen Is Your Best Friend This Summer
Sylvester Comprehensive Cancer Center

Soaking up rays by the beach or pool feels good, but it's harsh for your skin. The United States lacks advanced formula sunscreens found in Europe and other countries, so experts at Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, advocate better use of the products we have.



close
0.12857